Endoplast ApS

CVR 40866442 · Private limited company (ApS) · Active · Low risk

Endoplast ApS is a Private limited company (ApS), founded on , based in Hårlev. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 6 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -269k and a net result of DKK 100k. CEO: Thomas Foldberg.

Bankruptcy risk for Endoplast ApS

0.4%
probability of bankruptcy within 12 months
Low risk

0.3 × the average (1.41%) · higher risk than 57% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Current ratio50%–100% · bankruptcy rate 11.7%1.3×
Audit opted outYes · bankruptcy rate 10.4%1.2×

Reduces the risk

Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Published annual reports5–10 · bankruptcy rate 6.3%0.72×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
40866442
Status
Active
Company type
Private limited company (ApS)
Founded
(7 years)
Address
Håndværkervej 4
4652 Hårlev
Municipality
Stevns
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 40k
Auditor
2talRevision Registreret revisionsfirma
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 6
Missing annual reportNo
Negative equityYes
Equity ratio-52.6%
Current ratio65%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address7
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 169kDKK 26k
Net profitDKK 100kDKK -19k
EquityDKK -269kDKK -369k
Total assetsDKK 510kDKK 361k
CashDKK 357k–
Short-term debtDKK 779k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · 2talRevision Registreret revisionsfirma.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025124
1 Jan 2024 – 31 Dec 2024122
1 Jan 2023 – 31 Dec 2023172
1 Jan 2022 – 31 Dec 2022156
1 Jan 2021 – 31 Dec 202125
16 Oct 2019 – 31 Dec 202041

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOThomas FoldbergCurrent
Owner (100%)TACC Holding ApSCurrent
Owner (100%)Thomas Foldberg
FounderThomas FoldbergCurrent

The CEOs' other companies

Thomas Foldberg – 1 other companies

Address history (2 moves)

Håndværkervej 4, 4652 Hårlev
Postvej 1, 4652 Hårlev
Lindeengen 121, 2740 Skovlunde

Other companies at the same address

Questions and answers about Endoplast ApS

Has Endoplast ApS gone bankrupt?

No, Endoplast ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Endoplast ApS?

Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.

Who is the CEO of Endoplast ApS?

Thomas Foldberg is the CEO of Endoplast ApS.

Who is the auditor of Endoplast ApS?

Endoplast ApS most recently used 2talRevision Registreret revisionsfirma.

When was Endoplast ApS founded?

Endoplast ApS was founded on 16 October 2019.

What is the equity of Endoplast ApS?

Equity was DKK -269k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.